Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,505.70
-5.40 (-0.36%)
May 13, 2025, 3:29 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 158.09 billion as of May 13, 2025. Its market cap has decreased by -6.35% in one year.
Market Cap
158.09B
Enterprise Value
155.28B
Revenue
10.89B
Ranking
n/a
PE Ratio
48.45
Stock Price
1,505.70
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 158.09B, an increase of 60.28%. That is a compound annual growth rate of 31.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 157.52B | -31.89% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,186.36B |
| Divi's Laboratories | 1,599.58B |
| Cipla | 1,195.31B |
| Apollo Hospitals Enterprise | 995.85B |
| Mankind Pharma | 993.57B |
| Zydus Lifesciences | 890.37B |
| Aurobindo Pharma | 676.29B |
| Alkem Laboratories | 591.43B |